E1	Condition:T1 Name:T2
E7	Procedure:T7 Name:T8
E9	Procedure:T9 Name:T10
E10	Age:T13 Numeric-Filter:E4
E2	Condition:T5 Name:T6
E4	Eq-Comparison:T16 Operator:T17 Temporal-Unit:T12 Value:T14
E5	Assertion:T18 Asserted:E8
E8	Observation:T20 Name:T21
E11	Observation:T22 Name:T23 Polarity:T24
E13	Condition:T25 Name:T28 Temporality:E14
E14	Eq-Comparison:T26 Temporal-Period:T27
E3	Drug:T3 Name:T4
E15	Drug:T29 Name:T30
E16	Allergy:T31 Name:E3 Name2:E15
E18	Eq-Comparison:T33 Temporal-Period:T34
E19	Modifier:T35 Modifies:T2
T1	Condition 558 571	renal disease
T2	Condition-Name 558 571	renal disease
T7	Procedure 323 331	infusion
T8	Procedure-Name 323 331	infusion
T9	Procedure 416 433	ZULRESSO infusion
T10	Procedure-Name 416 433	ZULRESSO infusion
T11	Life-Stage-And-Gender 154 160	female
T12	Eq-Temporal-Unit 173 178	years
T13	Age 182 185	age
T14	Eq-Value 170 172	18
T5	Condition 143 153	ambulatory
T6	Condition-Name 143 153	ambulatory
T16	Eq-Comparison 161 178	at least 18 years
T17	Eq-Operator 161 169	at least
T18	Assertion 255 261	agrees
T20	Observation 276 293	primary caregiver
T21	Observation-Name 276 293	primary caregiver
T22	Observation 366 380	pregnancy test
T23	Observation-Name 366 380	pregnancy test
T24	Polarity 357 365	negative
T25	Condition 474 477	PPD
T26	Eq-Comparison 453 460	current
T27	Eq-Temporal-Period 453 460	current
T28	Condition-Name 474 477	PPD
T3	Drug 608 620	progesterone
T4	Drug-Name 608 620	progesterone
T29	Drug 624 640	allopregnanolone
T30	Drug-Name 624 640	allopregnanolone
T31	Allergy 597 604	allergy
T33	Eq-Comparison 69 74	prior
T34	Eq-Temporal-Period 69 74	prior
T35	Modifier 548 557	end stage
A1	Life-Stage-And-Gender-Type T11 female
A2	Eq-Temporal-Unit-Value T12 year
A3	Eq-Operator-Value T17 LTEQ
A5	Assertion-Type-Value E5 hypothetical
A6	Polarity-Value T24 negative
A8	Eq-Temporal-Period-Value T27 present
A9	Eq-Temporal-Period-Value T34 past
A10	Observation-Type-Value E11 lab
R1	During Arg1:E8 Arg2:E7
R2	Before Arg1:E11 Arg2:E9
R3	Or Arg1:E3 Arg2:E15
